US Bancorp
BCAX

US Bancorp’s Bicara Therapeutics BCAX Stock Holding History

US Bancorp’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.99K Buy
251
+17
+7% +$293 ﹤0.01% 3571
2025
Q4 		$3.94K Sell
234
-1
-0.4% -$17 ﹤0.01% 3615
2025
Q3 		$3.71K Sell
235
-175
-43% -$1.96K ﹤0.01% 3617
2025
Q2 		$3.81K Sell
410
-157
-28% -$1.87K ﹤0.01% 3716
2025
Q1 		$7.39K Buy
+567
New +$7.53K ﹤0.01% 3538

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return